Key result
Intravenous magnesium sulfate effectively abolished torsades de pointes in all 7 children with long QT syndrome without shortening the QTc interval.
Why the study?
Does intravenous magnesium sulfate abolish torsades de pointes in children with long QT syndrome?
Observational (n=7)
Does intravenous magnesium sulfate abolish torsades de pointes in children with long QT syndrome?
Intravenous magnesium sulfate is effective for abolishing torsades de pointes in children with long QT syndrome without shortening the QTc interval.
Answers are grounded in this paper and cite their sources.
May support acute use for torsades in pediatric long QT syndrome; case reports leave open need for controlled confirmation.
BACKGROUND: Administration of magnesium sulfate (MgSO4) is an effective and safe treatment for torsades de pointes (TdP) associated with acquired long QT syndrome (LQTS) in adults. As for children, there are few reports focusing on it. The authors discuss the efficacy of MgSO4 for TdP in children with congenital and acquired LQTS. The authors also discuss the optimal administration dosage and serum magnesium (SMg) concentration during MgSO4 therapy. METHODS: The authors studied seven consecutive LQTS children undergoing MgSO4 therapy for TdP. Of the seven children, five were congenital LQTS and two were acquired LQTS. A bolus injection of MgSO4 was given intravenously over 1-2 min followed by continuous infusion for the next 2-7 days. RESULTS: Of the seven patients, six responded completely to the initial bolus. The bolus dosage was 5.9 +/- 3.8 mg/kg (range, 2.3-12 mg/kg) in these six, and the other remaining one (neonate with congenital LQTS) required a total of 30 mg/kg until complete abolishment. The continuous infusion was given at rates of 0.3-1.0 mg/kg per h and patients did not show recurrence of TdP. The SMg concentration was 3.9 +/- 1.0 mg/dL (2.9-5.4 mg/dL) immediately after bolus injection. The mean corrected QT (QTc) interval before and after bolus injection did not show significant difference. CONCLUSION: Intravenous infusion of MgSO4 was effective for TdP in children with LQTS, and MgSO4 abolished TdP without shortening the QTc interval. The optimal bolus dosage, infusion rates and SMg concentration were 3-12 mg/kg, 0.5-1.0 mg/kg per h and 3-5 mg/dL, respectively.
No takes yet. Share an insight, caveat, or question.
Hoshino et al. (2006) conducted an observational in Torsades de pointes in children with long QT syndrome (n=7). Magnesium sulfate (MgSO4) was evaluated on Complete abolishment of torsades de pointes. Intravenous magnesium sulfate effectively abolished torsades de pointes in all 7 children with long QT syndrome without shortening the QTc interval.
Synapse has enriched 10 related papers. Consider them for comparative context: